Literature DB >> 11534770

Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells.

M S Kim1, H J Kang, A Moon.   

Abstract

Curcumin, a dietary pigment in turmeric, posseses anti-carcinogenic and anti-metastatic properties. The present study was conducted to study in vitro chemopreventive effects of curcumin in transformed breast cells. Here, we show that curcumin inhibits H-ras-induced invasive phenotype in MCF10A human breast epithelial cells (H-ras MCF10A) and downregulates matrix metalloproteinase (MMP)-2 dose-dependently. Curcumin exerted cytotoxic effect on H-ras MCF10A cells in a concentration-dependent manner. Curcumin-induced cell death was mainly due to apoptosis in which a prominent downregulation of Bcl-2 and upregulation of Bax were involved. We also suggest a possible involvement of caspase-3 in curcumin-induced apoptosis. Curcumin treatment resulted in the production of reactive oxygen species (ROS) in H-ras MCF10A cells. Apoptotic event by curcumin was significantly inhibited by pretreatment of an antioxidant N-acetyl-L-cysteine (NAC), suggesting redox signaling as a mechanism responsible for curcumin-induced apoptosis in H-ras MCF10A cells. Taken together, our results demonstrate that curcumin inhibits invasion and induces apoptosis, proving the chemopreventive potential of curcumin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534770     DOI: 10.1007/BF02975105

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  20 in total

1.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Endonuclease G promotes cell death of non-invasive human breast cancer cells.

Authors:  Alexei G Basnakian; Eugene O Apostolov; Xiaoyan Yin; Stanley O Abiri; Anna G Stewart; Amar B Singh; Sudhir V Shah
Journal:  Exp Cell Res       Date:  2006-09-20       Impact factor: 3.905

3.  Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.

Authors:  Susan R Mallery; Daren Wang; Brian Santiago; Ping Pei; Caroline Bissonnette; Jayanetti Asiri Jayawardena; Steven P Schwendeman; Richard Spinney; James Lang
Journal:  Mol Cancer Ther       Date:  2019-09-12       Impact factor: 6.261

Review 4.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

5.  A curcumin analog CA-5f inhibits urokinase-type plasminogen activator and invasive phenotype of triple-negative breast cancer cells.

Authors:  Minjoo Kim; Aree Moon
Journal:  Toxicol Res       Date:  2021-11-17

Review 6.  Molecular targets of curcumin for cancer therapy: an updated review.

Authors:  Pandima Devi Kasi; Rajavel Tamilselvam; Krystyna Skalicka-Woźniak; Seyed Fazel Nabavi; Maria Daglia; Anupam Bishayee; Hamidreza Pazoki-Toroudi; Seyed Mohammad Nabavi
Journal:  Tumour Biol       Date:  2016-07-28

7.  Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.

Authors:  Huang-Ge Zhang; Helen Kim; Cunren Liu; Shaohua Yu; Jianhua Wang; William E Grizzle; Robert P Kimberly; Stephen Barnes
Journal:  Biochim Biophys Acta       Date:  2007-05-01

Review 8.  Turmeric: Reemerging of a neglected Asian traditional remedy.

Authors:  Parviz Khajehdehi
Journal:  J Nephropathol       Date:  2012-04-05

9.  Cancer-linked targets modulated by curcumin.

Authors:  Noor Hasima; Bharat B Aggarwal
Journal:  Int J Biochem Mol Biol       Date:  2012-12-24

10.  A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.

Authors:  Jeffrey D Altenburg; Andrew A Bieberich; Colin Terry; Kevin A Harvey; Justin F Vanhorn; Zhidong Xu; V Jo Davisson; Rafat A Siddiqui
Journal:  BMC Cancer       Date:  2011-04-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.